Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies

Inclusion Criteria: * Adult (aged 18 or over). * Patient seen while hospitalized or in outpatient awaiting hospitalization. * HIV1 or HIV2 infection confirmed by techniques validated in France and in Suriname, either before the episode considered, or discovered concomitantly. * Patient presenting at least one of the three followings items: an alteration of their general condition (with a grade 1 according to the WHO Performance Status scale) and/or a fever and/or symptoms suggestive of an infectious syndrome. * Medical prescription for the collection of blood and urine specimens to test for an infectious agent within 7 days following admission to the hospital. * Written consent to participate in the study obtained. Exclusion Criteria: * Refusal to participate in the study. * Patient in a critical condition that doesn't allow physicians to get an informed consent without a legal representative to represent him and sign a consent form for the patient participation in the study. * Ongoing antifungal treatment or antifungal treatment stopped during the month preceding the inclusion date (topic antifungal therapy not considered at this point). * Patient in detention at the time of admission to the hospital.